Pure Global AI
NCT06333080Recruiting

The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin

The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin (DIACRON) - An Open-label Clinical Trial
Aalborg University HospitalClinicalTrials.gov
Verified
Study focus
Disease/Condition
Diabetes Mellitus, Type 2
Study type
Observational
Sponsor & location
Primary sponsor
Aalborg University Hospital
Location
Aalborg, Denmark
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Mar 01, 2025
Enrollment
20 participants
Primary outcome

Time-in-Range (TIR)

Summary

The objective of the trial is to investigate the effect of adherence to oral semaglutide
 dosing instructions on glycaemic control in people with type 2 diabetes, which are
 dysregulated on metformin and naïve to second line antidiabetic treatment.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06333080
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06333080 through Pure Global AI's free database. This phase not specified trial is sponsored by Aalborg University Hospital and is currently Recruiting. The study focuses on Diabetes Mellitus, Type 2. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.